BERGISCH GLADBACH, June 14, 2017 – The new MACSprep™ PBMC Isolation Kit, human from Miltenyi Biotec allows the preparation of highly pure peripheral blood mononuclear cells (PBMCs) from human whole blood without density gradient centrifugation in only 25 min. The kit is ideal for the processing of small blood samples.
Miltenyi Biotec has developed the MACSprep PBMC Isolation Kit, human for the straightforward isolation of PBMCs from 2–10 mL human whole blood without density gradient centrifugation.
Your advantages with the new MACSprep PBMC Isolation Kit, human are:
- Fast and easy PBMC preparation from whole blood in only 25 min
- No density gradient centrifugation needed
- Ready-to-use for up to 10 mL whole blood samples
The isolation can be easily performed in a two-step separation procedure: During the first isolation step erythrocytes are aggregated and sedimented. In a second step, non-PBMCs are depleted based on MACS® Technology, resulting in highly pure PBMCs ready to be used for downstream experiments. Fields of application include PBMC co-cultures for functional immune cell assays, studies on cytokine expression of immune cells upon restimulation, studies on signal transduction during activation of immune cells and immune monitoring of antigen-specific T cells, for example.
MACSprep™ PBMC Isolation Kit, human
For further information see miltenyibiotec.com/pbmc
Meet us at one of the following events:
June 10–14, 2017 CYTO 2017, Boston, MA, USA
June 14–17, 2017 ISSCR 2017, Boston, MA, USA
June 29–30, 2017 20th Meeting on T-Cells Subsets and Functions 2017, Marburg, Germany
About Miltenyi Biotec
Miltenyi Biotec is a global provider of products and services that advance biomedical research and cellular therapy. The company’s innovative tools support research at every level, from basic research to translational research to clinical application. This integrated portfolio enables scientists and clinicians to obtain, analyze, and utilize the cell. Miltenyi Biotec’s technologies cover techniques of sample preparation, cell isolation, cell sorting, flow cytometry, cell culture, molecular analysis, and preclinical imaging. Their more than 25 years of expertise spans research areas including immunology, stem cell biology, neuroscience, and cancer, and clinical research areas like hematology, graft engineering, and apheresis. In their commitment to the scientific community, Miltenyi Biotec also offers comprehensive scientific support, consultation, and expert training. Today, Miltenyi Biotec has more than 1,800 employees in 25 countries – all dedicated to helping researchers and clinicians around the world make a greater impact on science and health. For more information please visit www.miltenyibiotec.com
Press contact:
Miltenyi Biotec
Dr. Anja Kohmann
Communications Manager
anja.kohmann@miltenyibiotec.de
Publication free of charge – Specimen copy requested.